Medicaid chemical dependency patients in a commercial health plan: Do high medical costs come down over time?

Journal of Behavioral Health Services and Research

Volumn 32, Issue 3, 2005, Pages 253-263

  Walter, Lawrence J ^a   Ackerson, Lynn ^a   Allen, Steven ^b  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MANAGED CARE ORGANIZATION; MEDICAID; OUTPATIENT CARE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CALIFORNIA; CAPITATION FEE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE SELECTION BIAS; MALE; MEDICAID; ORGANIZATIONS, NONPROFIT; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 22244439500     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02291826     Document Type: Article

References (30)

1. Alexandre PK, Roebuck MC, French MT, Chitwood DD, McCoy CB. Problem drinking, health services utilization, and the cost of medical care. In: Services Research in the Era of Managed Care. New York: Kluwer Academic/Plenum; 2001:285-298.
2. Galanter M, ed. Recent Developments in Alcoholism; Vol 15.
3. French MT, McGeary KA, Chitwood DD, et al. Chronic illicit drug use, health services utilization and the cost of medical care. Social Science Medicine. 2000;50:1703-1713.
4. Holder HD, Lennox RD, Blose JO. The economic benefits of alcoholism treatment: a summary of twenty years of research. Journal of Employee Assistance Research. 1992;1:63-82.
5. McGeary KA, French MT. Illicit drug use and emergency room utilization. Health Services Research. 2000;35:153-169.
6. Parthasarathy S, Weisner C, Hu TW, et al. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. Journal of Studies on Alcohol. 2001;62:89-97.
7. Parthasarathy S, Mertens J, Moore C, et al. Utilization and cost impact of integrating substance abuse treatment and primary care. Medical Care. 2003;41:357-367.
8. Stein MD, O'Sullivan PS, Ellis P, et al. Utilization of medical services by drug abusers in detoxification. Journal of Substance Abuse. 1993;5:187-193.
9. Jones KR, Vischi TR. Impact of alcohol, drug abuse and mental health treatment on medical care utilization. A review of the research literature. Medical Care. 1979;17:1-82.
10. Holder HD. The cost offsets of alcoholism treatment. In: The Consequences of Alcoholism. New York: Plenum Press; 1998:361-374.
11. Galanter M, ed. Recent Developments in Alcoholism; Vol 14.
12. Burke KC, Meek WJ, Krych R, et al. Medical services use by patients before and after detoxification from benzodiazepine dependence. Psychiatric Services. 1995;46:157-160.
13. Hoffmann NG, DeHart SS, Fulkerson JA. Medical care utilization as a function of recovery status following chemical addictions treatment. Journal of Addictive Diseases. 1993;22:97-108.
14. Lennox RD. Cost-offsets of drug-abuse treatment provided in the private sector. Invited paper presented at: Annual Meeting of the Association for Health Services Research; June 27-29, 1993; Washington, DC.
15. Walter LJ, Parthasarathy S, Allen S, et al. Medicaid patients in a private health maintenance organization: patterns of chemical dependency treatment. The Journal of Behavioral Health Services Research. 2002;29:1-14.
16. SAS Institute Inc. SAS/STAT(c) User's Guide, Version 8. Vols 1 and 2. Cary, NC: SAS Institute Inc; 1999:3884.
17. Selby JV. Linking automated databases for research in managed care settings. Annals of Internal Medicine. 1998;127:719-724.
18. Ray GT, Lieu TA, Weinstein MC, et al. Comparing the medical expenses of children with Medicaid and commercial insurance in an HMO. The American Journal of Managed Care. 2000;6:753-760.
19. D'Agostino Jr RB. Tutorial inbiostatistics: propensity score methods forbias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine. 1998;17:2265-2281.
20. Diehr P, Yanez D, Ash A, et al. Methods for analyzing health care utilization and costs. Annual Review Public Health. 1999;20:125-144.
21. McCullagh P, Nelder JA. Generalized Linear Models. New York: Chapman & Hall; 1989.
22. Wolfinger R, O'Connell M. Generalized linear mixed models: a pseudo-likelihood approach. Journal of Statistical Computation and Simulation. 1993;48:233-243.
23. Health Care Financing Administration. A Profile of Medicaid Chart Book 2000. Rockville, Md: Health Care Financing Administration; 2000.
24. Salganicoff A. Medicaid and managed care: implications for low-income women. Journal of the American Medical Women's Association. 1997;52:78-80.
25. American Society of Addiction Medicine. ASAM Patient Placement Criteria. 2nd ed. Chevy Chase, Md: American Society of Addiction Medicine; 2000.
26. Stein MD. Medical consequences of substance abuse. Psychiatric Clinics of North America. 1999;22:351-370.
27. Felt-Lisk S, Dodge R, McHugh M. Trends in Health Plans Serving Medicaid - 2000 Data Update. Washington, DC: The KaiserCommission on Medicaid & the Uninsured; 2001.
28. Ettner SL, Frank RG, Mcguire TG. Risk adjustment alternatives in paying for behavioral health care under Medicaid. HSR: Health Services Research. 2001;36:793-811.
29. Ettner SJ, Johnson S. Do adjusted clinical groups eliminate incentives for HMOs to avoid substance abusers: evidence from the Maryland Medicaid HealthChoice Program. Journal of Behavioral Health Services Research. 2003;30:63-77.
30. Partnership HealthPlan of California. Partnership HealthPlan of California 2000-2001 Annual Report. Suisun City, Calif: Partnership HealthPlan of California; 2001.